MedTrace Logo

Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

NCT04529252 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-24

No results posted yet for this study

Summary

The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and phenotypic presentations of both.

Conditions

  • Spinocerebellar Ataxias
  • Cerebellar Ataxia
  • Nucleotide Repeat Disease

Interventions

OTHER

Specimen collection

Blood, urine, stool, cerebrospinal fluid, and skin biopsy may be collected

Sponsors & Collaborators

Principal Investigators

  • Zbigniew K Wszolek, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-17
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529252 on ClinicalTrials.gov